Evenity denied as not medically necessary by Aetna?

Aetna's specific coverage criteria for evenity are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Aetna Denied Evenity for Medical Necessity

Evenity (romosozumab) is an anabolic bone-forming agent approved for osteoporosis in postmenopausal women at high fracture risk. Medical-necessity denials from Aetna typically occur when the clinical documentation submitted at prior authorization does not clearly establish that the patient meets all of Aetna's coverage criteria — which generally include bone density findings, fracture history, and prior treatment with other osteoporosis therapies. The plan may also deny if the prescriber's notes do not explicitly address each criterion in Aetna's clinical policy. You should obtain Aetna's operative clinical policy for romosozumab to confirm the exact criteria that apply to your plan.

## Why This Denial Is Appealable

Medical-necessity denials are overturned when the clinical record, properly organized and submitted, demonstrates that every coverage criterion is met. Aetna's clinical reviewers work from what was submitted — if critical records were missing from the original authorization request, the appeal is an opportunity to supply them. You are entitled to a full internal appeal under ERISA §503 or your state's insurance law, and to independent external review under ACA §2719 after internal remedies are exhausted, generally within approximately four months of the final internal denial. Expedited review is available if your physician certifies that a standard timeline would seriously jeopardize your health.

## Your Appeal Timeline

1. Request the complete denial letter identifying every criterion Aetna found unmet. 2. Obtain Aetna's clinical policy for Evenity/romosozumab. 3. Gather documentation addressing each unmet criterion. 4. File the first-level internal appeal within the deadline on your Explanation of Benefits. 5. Escalate to external review if internally denied.

## Documentation to Gather

• Diagnosis confirmation: DXA scan reports with T-scores, fracture risk assessment tool output, and any fragility fracture history (with radiology reports).
• Prior treatment history with outcomes: A chronological list of every prior osteoporosis medication tried, with start dates, stop dates, and documented reasons for discontinuation (inadequate response, adverse effect, intolerance) — supported by pharmacy records and office notes.
• Clinical severity: Physician notes documenting cumulative fracture burden, fall risk, functional limitations, and overall fracture-risk assessment.
• Prescriber medical-necessity letter: A detailed letter from your prescribing endocrinologist or specialist addressing each criterion in Aetna's policy, explaining why prior therapies were insufficient, and affirming that Evenity is appropriate under the current relevant clinical practice guidelines.
• Relevant guideline reference: The prescriber's letter may cite the applicable guideline organization (e.g., Endocrine Society, ASBMR, or NOF) without needing to reproduce specific numbers.

## Criteria-Mapping Structure

List every criterion from Aetna's clinical policy. For each one, provide the specific chart evidence:

| Aetna Policy Criterion | Your Chart Evidence | |---|---| | Diagnosis of osteoporosis established | Cite DXA report date and findings | | High fracture risk documented | Cite fracture history or risk assessment | | Prior therapy requirement met | Cite medication list with dates and outcomes | | Prescribed by appropriate specialist | Cite prescriber's specialty and NPI |

A criterion-by-criterion table is the most efficient structure for a medical-necessity appeal and reduces the chance that a reviewer will overlook any evidence you have submitted.